Acceder

Información de Marsh & McLennan (MMC)

153791 suscriptores
Marsh & McLennan (MMC)
Marsh & McLennan (MMC)

Noticias sobre Marsh & McLennan (MMC)

Amarin (NASDAQ:AMRN) Q4 results ($M): Revenues: 16.5 (+63.5%); Operating Expenses: 30.8 (-20.8%); Net Loss: (19.7) (-27.6%); Loss Per Share: (0.11) (+59.3%); Quick Assets: 119.5 (-37.6%). Vascepa revenue of $16.5M represented a sequential increase of...
report Q4 ARNA Arena Pharmaceuticals (NASDAQ:ARNA): Q4 EPS of -$0.15 misses...
Arena Pharmaceuticals beats by $0.07, misses on revenue • 6:56 AM Mohit...
Agenda de la Semana (14/02 - 18/02)
Informes de Beneficios (destacados) Lunes: Agilent (A), Marriott (MAR), Masco...